Special Point: Several classes of medications can decrease the bodys ability to absorb vitamin B12
Figure artwork Figure artwork was created with BioRender.com
Some studies have shown that if we are overweight, obese, or have type 2 diabetes, our GLP-1 levels may be lower
As MC4R is involved in the regulation of cardiovascular function, there is concern that MC4R activation may affect those functions [24, 25]
Tirzepatide, administered as a weekly subcutaneous injection, and additional dual GLP-1/GIP receptor agonists that could eventually be developed in the future seem to be a promising furthest advance for the management of several cardiometabolic settings
AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor